Therapeutic Hypothermia With Propofol in Survival and Neurological Prognoses After Cardiac Arrest
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Therapeutic hypothermia has been proven to significantly improve the survival and
neurological prognoses in patients resuscitated from cardiac arrest. Propofol has been
reported to exhibit potentials in mitigating ischemia-reperfusion injury via the
antioxidative, anti-inflammatory and neuroprotective mechanisms. This study is to investigate
the potentials of propofol in further improving the survival and neurological prognoses in
this era of therapeutic hypothermia.